ecancer

Malignant brain tumours and the role of genetically engineered mice models

Dr Luis Parada - The University of Texas Southwestern Medical Center, Dallas, USA

10 Nov 2014

Young oncologists bridging the gap between translational and clinical cancer research

Prof Joan Seoane - Vall d’Hebron Institute of Oncology, Barcelona, Spain

29 Sep 2014

Navigating current treatment options for HER2-positive MBC: Patient journey 1

Dr Rupert Bartsch - Medical University of Vienna, Vienna, Austria

18 Sep 2014

New metronomic approach to neuroblastoma

Prof Frank Berthold - University Hospital Köln, Köln, Germany

10 Jul 2014

Cost-effectiveness of metronomic approach to neuroblastoma and its use in combination with other therapies

Dr Jaroslav Sterba - University Children’s Hospital Brno, Brno, Czech Republic

10 Jul 2014

Betablockers repurposed to treat neuroblastoma

Dr Eddy Pasquier - Children's Cancer Institute Australia, Randwick, Australia

10 Jul 2014

Personalised cancer medicine using the human protein atlas and affibodies

Prof Mathias Uhlén - Royal Institute of Technology (KTH), Stockholm, Sweden

26 Jun 2014

Novel drug targets and potential combinations in childhood brain tumours

Dr Stefan Pfister - German Cancer Research Center (DKFZ), Heidelberg, Germany

26 Jun 2014

ecancermedicalscience editor's choice for June 2014

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

24 Jun 2014

Role of AORTIC in dealing with rising cancer rates in Africa

North American Vice president of AORTIC

1 May 2014

Toll like receptor 7 agonists for cancer immunotherapy

Prof Stefan Endres - Ludwig-Maximilians-Universität, Munich, Germany

25 Mar 2014

The 1st Immunotherapy of Cancer Conference (ITOC)

Prof Heinz Zwierina - Innsbruck Medical University, Innsbruck, Austria

25 Mar 2014

More from ecancer